Iridex (IRIX) Return on Capital Employed (2011 - 2026)
Iridex (IRIX) recorded quarterly Return on Capital Employed of 6.55% in Q2 2026, down 10.5% quarter-over-quarter from 5.93% in Q1 2026, and down 1390.0% on a YoY basis from 0.51% in Q2 2025.
Iridex (IRIX) Return on Capital Employed (2011 - 2026) Analysis & Trends
Iridex's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 6.55% for Q2 2026.
- In Q2 2026, Return on Capital Employed fell 1390.0% year-over-year to 6.55%; the TTM figure through Apr 2026 stood at 6.55% (down 1390.0% YoY), while the FY2026 annual figure was 5.78%, up 642.0% from the prior year.
- Return on Capital Employed was 6.55% for Q2 2026 at Iridex, down from 5.93% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 19.27% in Q3 2025 to a low of 73.28% in Q3 2024.
- Historically, Return on Capital Employed has averaged 23.68% across 5 years, with a median of 23.03% in 2022.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 4071 bps in 2024, then jumped 9255 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 24.2% in 2022, then plunged by 90 bps to 46.08% in 2023, then jumped by 69 bps to 14.2% in 2024, then soared by 236 bps to 19.27% in 2025, then slumped by 134 bps to 6.55% in 2026.
- The last three Return on Capital Employed figures came in at 6.55% (Q2 2026), 5.93% (Q1 2026), and 19.27% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn | -6.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -6.55% |
| Jan 3, 2026 | -5.93% |
| Sep 27, 2025 | 19.27% |
| Jun 28, 2025 | 15.25% |
| Mar 29, 2025 | 7.35% |
| Dec 28, 2024 | -14.20% |
| Sep 28, 2024 | -73.28% |
| Jun 29, 2024 | -64.75% |
| Mar 30, 2024 | -60.20% |
| Dec 30, 2023 | -46.08% |
| Sep 30, 2023 | -32.57% |
| Jul 1, 2023 | -31.22% |
| Apr 1, 2023 | -26.72% |
| Dec 31, 2022 | -24.20% |
| Oct 1, 2022 | -23.31% |
| Jul 2, 2022 | -22.75% |
| Apr 2, 2022 | -19.07% |
| Jan 1, 2022 | -17.27% |
| Oct 2, 2021 | -18.59% |
| Jul 3, 2021 | -19.45% |